Rainmed Medical Limited submitted its January 2026 monthly return on 5 February 2026. The company reported that its authorized share capital remains at 3,800,000,000 ordinary shares, each with a par value of HKD 0.0001, totaling HKD 380,000. No changes were recorded during the month.

The number of issued shares (excluding treasury shares) at the end of January 2026 was 1,401,358,800, matching the previous month’s figure. No treasury shares were held, and the public float requirement of 25% was confirmed as being satisfied.

Under the Pre-IPO Share Option Scheme adopted on 10 December 2021 with an exercise price of HKD 3.90, 22,789,050 share options were outstanding at the beginning of January. A total of 438,000 options were canceled during the month, leaving 22,351,050 outstanding share options. No additional new shares were issued or transferred to satisfy exercises of these options.